Analysis

A dramatic 41% plunge in short interest during March tells a compelling story. Coeur Mining, having completed its transformative acquisition...

The stock of semiconductor equipment maker Aixtron has surged nearly 88% since the start of the year, a rally fueled...

A critical legal hearing scheduled for May 6 in Delaware could resolve a major uncertainty hanging over gene therapy developer...

ImmunityBio is navigating a stark divide. While its commercial engine, driven by the cancer drug Anktiva, is firing on all...

Ethereum surged 8.9% to $2,388 on Tuesday, decisively outperforming Bitcoin and leading a broad crypto market recovery. This rally, however,...

While corporate Bitcoin purchases have nearly ground to a halt globally, one company continues its relentless accumulation. Strategy executed another...

The fate of German agricultural and energy group BayWa rests on a precarious convergence of events slated for the final...

The U.S. Food and Drug Administration has delivered a potentially fatal blow to Replimune Group Inc., issuing a second complete...

Red Cat Holdings is accelerating the development of its autonomous systems ecosystem on multiple fronts, with a series of strategic...

The stock of telehealth provider Hims & Hers has been under significant pressure, trading roughly 40 percent below its level...